Met Life Investment Management, LLC Neuro Pace Inc Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 9,205 shares of NPCE stock, worth $119,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,205Holding current value
$119,204% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
65Shares Held
21.7MCall Options Held
23.2KPut Options Held
800-
Kck Ltd. Tortola, D85.27MShares$68.3 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$44.1 Million1.03% of portfolio
-
Morgan Stanley New York, NY2.49MShares$32.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$31.5 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$19.2 Million7.02% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $322M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...